a b s t r a c t C/EBPd is a tumour suppressor transcription factor that induces gene expression involved in suppressing cell migration. Here we investigate whether C/EBPd-dependent gene expression also affects cell responses to nanometric topology. We found that ablation of the C/EBPd gene in mouse embryonal fibroblasts (MEFs) decreased cell size, adhesion and cytoskeleton spreading on 240 nm and 540 nm nanometric grooves. ChIP-SEQ and cDNA microarray analyses demonstrated that many binding sites for C/EBPd, and the closely related C/EBPb, exist throughout the mouse genome and control the upregulation or downregulation of many adjacent genes. We also identified a group of C/EBPd-dependent, transregulated genes, whose promoters contained no C/EBPd binding sites and yet their activity was regulated in a C/EBPd-dependent manner. These genes include signalling molecules (e.g. SOCS3), cytoskeletal components (Tubb2, Krt16 and Krt20) and cytoskeletal regulators (ArhGEF33 and Rnd3) and are possibly regulated by cis-regulated diffusible mediators, such as IL6. Of particular note, SOCS3 was shown to be absolutely required for efficient cell spreading and contact guidance on 240 nm and 540 nm nanometric grooves. C/EBPd is therefore involved in the complex regulation of multiple genes, including cytoskeletal components and signalling mediators, which influence the nature of cell interactions with nanometric topology.
Introduction
C/EBP proteins form a highly conserved family of leucine zipper (bZIP) transcriptional factors that serve as master regulators of cellular processes such as the cell cycle, differentiation, and inflammatory responses [1] . So far, six C/EBP genes have been isolated (a, b, g, d, ε, and z), although protein numbers may well be higher due to variation in polypeptide size through alternate splicing and protein processing [2] . C/EBP isoforms are structurally similar, displaying a characteristic basic leucine zipper domain at the C terminus (90% homology between isoforms), which facilitates dimerization and DNA binding [2] . However, C/EBP isoforms are functionally and genetically distinct, with their transcriptional activation domains less well conserved (<20% sequence identity between isoforms). This divergence gives rise to the wide range of cellular responses in which C/EBP isoforms have been implicated [2] .
Attention has recently turned to the functional role of the C/EBPd isoform, which represents a ubiquitously expressed transcriptional activator that is robustly induced in a variety of G 0 growth arrested cells [3] . Importantly, "loss of function" alterations in C/EBPd have been reported in breast cancer [4e6] and acute myeloid leukaemia (AML) [7] and are generally associated with impaired contact inhibition, increased genomic instability and increased cell migration [8] . The use of knockout mice demonstrated that C/EBPd has a vital role in mammary duct and epithelial cell proliferation [9] as well as an obligate role in the differentiation of preadipocytes [10, 11] . In addition, recent work suggests that C/EBPd is required for the maintenance of pluripotency in human limbic stem cells [2] . C/EBPd activity appears to be regulated at a number of levels, including transcriptional (gene induction by STAT3, Sp1, CREB and NcoA/SRC-1 [12, 13] ), post-transcriptional (mRNA stability [14] ) and post-translational (ubiquitinylation [15] and SUMOylation [16] ) mechanisms. Certain C/EBP isoforms have also been shown to be substrates for various protein kinases, including the MAP kinases, ERK 1 and 2, and protein kinase C (PKC) [1] , and are targets of second messenger signalling pathways. For example, elevations in the intracellular levels of cyclic AMP and activation of protein kinase A, has a direct impact on the induction of the constitutively active C/ EBPd isoform, which, in turn, regulates the acute-phase plasma protein gene haptoglobin, which is involved in the intestinal epithelial cell response to inflammation [12] , whereas cyclic AMPactivation of exchange protein activated by cyclic AMP 1 (EPAC1), leads to the C/EBPd-dependent induction of the anti-inflammatory suppressor of cytokine signalling 3 (SOCS3) gene in vascular endothelial cells [17] . Despite being a transcriptional activator, very few C/EBPd target genes have been identified. As a result the mechanisms by which C/EBPd controls cell adhesion, migration, differentiation and cell-cycle progression remain poorly understood. Recent reports have demonstrated that sumoylation of C/EBPd promotes sequestration to the nuclear periphery, thereby suppressing expression of C/EBPd-dependent genes associated with cell adhesion, including glycoprotein V, protocadherin 9 and integrin b8 [8, 16] . Given this potential link between transcriptional control and cell adhesion we have used genomic analysis (including gene array and high resolution DNA sequencing) to investigate the role of C/ EBPd in controlling cell adhesion with biomaterials, comparing planar and nanometric grooved growth surfaces.
Materials and methods

Materials
Wild type (WT) immortalized mouse embryonic fibroblasts (129SV:C57CI/6, MEFs) and MEFs containing homozygous deletions of the C/EBPb, or C/EBPd genes were generous gifts from Prof. Peter Johnson (C/EBPb) and Esta Sterneck (C/EBPd) from NCI, National Institutes of Health, Frederick, MD. SOCS3 and FAK knockout MEFs, together with matched WT cells, were gifts from Prof. Margaret Frame, Edinburgh Cancer Research UK Centre, UK and Dr Timothy Palmer, Institute of Cardiovascular and Medical Sciences, University of Glasgow, UK, respectively. Forskolin, and rolipram were purchased from Merck Biosciences (Nottingham, UK). Anti-SOCS3 and ChIP-grade, anti-C/EBP polyclonal antibodies were from Santa Cruz.
Generation of grooved and planar growth surfaces
Microstructured quartz substrates were fabricated by acid-cleaning (7:1H 2 SO 4 :H 2 O 2 for 5 min) quartz slides which were then spin-coated with AZ primer (4000 rpm for 30sec). A layer of Shipley S1818 photoresist (Shipley) was spun onto to the spin-coated slides and then soft-baked for 30 min in a 90 C oven. The substrates were UV treated on an MA6 mask aligner with exposure energy of ca. given a 30 s treatment in oxygen plasma to allow cell attachment (Harrick Plasma, USA). All PCL substrates were sterilised in ethanol for 30 min, then transferred through three rinses in sterile 1Â PBS and two rinses in complete medium.
Cell culture and growth of cells on biomaterials
Matched wild type (WT) or homozygous knockout (À/À) mouse embryonic fibroblasts (MEFs), for C/EBPb, C/EBPd, SOCS3 or FAK, were maintained in 71% (v/v) DMEM (Sigma), supplemented with 17.7% (v/v) medium 199, 9% (v/v) FBS, 1% (v/v) 200 mM L-glutamine (Gibco), 0.9% (v/v) 100 mM sodium pyruvate and antibiotics (6.74 U/ml Penicillin-Streptomycin, 0.2 mg/ml Fungizone) at 37 C in a 5% CO 2 environment. Cells were passaged at 70e80% confluence, and the medium was replaced regularly. Unless otherwise indicated, MEFs were seeded at a density of 1 Â 10 4 cells/ml on the PCL thumb-embossed substrates with a 24 h culture period.
Immunofluorescence
MEFs were fixed in a 10% (v/v) formaldehyde solution (15min at 37 C), permeabilised (5min at 4 C) and blocked in 1% (w/v) BSA/PBS (15min at 37 C). The samples were then stained at 37oC for 1 h with 1:200 (v/v) anti-vinculin (clone hVin-1, Sigma) in 1% (w/v) BSA/PBS and 1:500 (v/v) phalloidin-rhodamine (Molecular Probes). In each experiment, two replicas each of planar and nanogroove topography were stained. Cells were washed 3 Â 5min in 1xPBS containing 0.5% (v/ v) Tween-20, and appropriate biotinylated secondary antibody (Vector Laboratories) was added at 1:50 in 1% (w/v) BSA/PBS and incubated for a further hour at 37 C. After washing, 1:50 (v/v) FITC-conjugated streptavidin (Vector Laboratories) was added to the samples and incubated for 30 min at 4 C followed by washing and mounting using Vectashield mountant with DAPI nuclear stain (Vector Laboratories). Cell images were captured on a confocal microscope and analysed using Image J software (NIH). Significant changes were determined by one-way ANOVA with Tukey post-test.
Microarray analysis
C/EBPb WT, C/EBPb À/À, C/EBPd WT and C/EBPd À/À cells were grown on planar growth surfaces and then incubated in the presence or absence of a combination of 10 mM forskolin plus 10 mM rolipram (F/R) for 5 h at 37 C in 5% (v/v) CO 2 . Cells were then washed with 1 Â 1 ml PBS and RNA was isolated using the Qiagen "RNeasy" Mini Kit according to the manufacturers protocol. RNA samples were additionally treated with a "DNA-free Kit" (Applied Biosystems) to remove any remaining DNA. RNA samples were then prepared for Affymetrix whole transcriptome microarray analysis, using the WT Expression Kit (Ambion) according to the manufacturer's instructions. Briefly, reverse transcription was used to prime poly(A) and nonpoly(A), but not ribosomal, mRNA and generate sense strand cDNA for fragmentation and labelling, using the Affymetrix GeneChip Ò WT Terminal Labelling Kit (PN 900671). Amplified and biotinylated sense-strand DNA targets were hybridised, using a Fluidic Station 400,to Affymetrix GeneChip Ò Mouse Gene 2.0 ST Array and data captured using an Affymetrix GeneChip Ò Scanner 3000 7G. Gene expression changes were selected where at least one fold change was greater than 2. Grouping of gene expression data into similarly responsive patterns was done using Treeview and CLUSTER software [18] , freely available from the Eisen lab (http://www.eisenlab. org/eisen/).
Chromatin immunoprecipitation and sequencing (ChIP-SEQ) analysis
C/EBPb WT and C/EBPd WT cells were stimulated in the presence or absence of a combination of 10 mM forskolin plus 10 mM rolipram (F/R) for 5 h at 37 C in 5% (v/ v) CO 2 . Cells were then fixed and chromatin extracted and sheared using the enzymatic "CHIP-IT Express Kit" (Active Motif) according to the manufacturer's instructions. Sheared chromatin from F/R-treated and non-treated cells was then immunoprecipitated at 4 C, overnight with 4 mg of either C/EBPb WT or C/EBPd
ChIP-grade antibodies (Santa Cruz). DNA fragments were eluted from immunoprecipitated chromatin and used to prepare a ChIP-SEQ DNA library for sequencing using the "ChIP-SEQ Sample Prep Kit" from Illumina, according to the manufacturer's protocols. Briefly, the first step in library preparation was to convert any overhangs in the ChIP'd DNA into phosphorylated blunt ends. The 3 0 ends were then adenylated and adaptors ligated onto the ends of the fragments. The library was then size selected on an agarose gel and eventually enriched by PCR. The enriched library samples were then loaded onto a flow cell at a concentration of 12pM and cluster formation was done on an Illumina Cluster station. Samples were then sequenced on an Illumina GA IIX giving 76bp reads.
ChIP-SEQ data analysis
The ChIP DNA was sequenced on an Illumina GA IIx, one lane of the flow cell per sample. The quality of the reads was assessed using Fastqc (www. bioinformatics.babraham.ac.uk/projects/fastqc/). The sequence reads were aligned to the mouse genome (release version mm9) using the bowtie aligner (version 0.12.7) (bowtie-bio.sourceforge.net/index.shtml) [19] , which was set up to report only uniquely aligning reads. Duplicate reads were removed using Samtools (version 0.1.18) [20] . The ChIP analysis was performed using the Homer (version 3.9) suite of tools (biowhat.ucsd.edu/homer/ngs/index.html) [21] . The pipeline for the analysis is shown in Supplementary Fig. 1 . Custom scripts were created to compare the list of known genes closest to ChIP peaks with gene lists generated from RNA microarray experiments. These corroborated gene lists were visualised on chromosomes using Circos plots (circos.ca; Supplementary Fig. 2 ) and Venn diagram (Fig. 2b) .
Reverse transcription PCR (RT-PCR)
Total RNA isolation was extracted from MEF WT and MEF À/À cells using an RNeasy Mini Kit (Qiagen) according to the manufacturer's instructions. RT-PCR reactions were carried out using the OneStep RT-PCR Kit from Qiagen. Briefly, 5e 10 ng of RNA per sample was used in 25 ul reaction mixture containing 0.4 mM dNTPs and 0.6 mM of each primer. The primer sequences used were mTubb2a In order to determine the role of C/EBPd transcription factor in regulating cell interaction with nanometric topology, embryonal fibroblasts isolated from wild type (MEF WT), or transgenic mice in which both alleles encoding C/EBPd had been deleted (MEF C/EBPd À/À), were grown on planar or nanogroove (240 nm or 540 nm depth, fixed 12.5 mm groove/ridge width (25 mm pitch)) surfaces. . Gene expression changes from microarray that are also identified by C/EBPd ChIP-SEQ CLUSTER analysis was carried out on gene expression ratio changes that were also identified by C/EBPd ChIP-SEQ, as described in the legend to Fig. 3 . Enlarged elements of the CLUSTER dendogram on the right represent groups of genes whose responsiveness to F/R treatment is dependent on the expression of either C/EBPb, C/EBPd, or both.
Cells were then fixed and immunostained with anti-actin and antivinculin antibodies (Fig. 1a) . From these experiments it was apparent that MEF WT cells spread normally on planar growth surfaces, possessing a well developed actin cytoskeleton and adhesion complexes, as indicated by phalloidin and vinculin staining respectively. In addition, MEF WT cells grown on 240 nm or 540 nm grooves became more elongated and aligned themselves along the direction of the nanogrooves (Fig. 1a) . In contrast, MEF C/ Fig. 5 . Gene expression changes from microarray that are also identified by both C/EBPb and C/EBPd ChIP-SEQ CLUSTER analysis was carried out on microarray gene expression changes that were also identified by ChIP-SEQ as genes with consensus binding sites for both C/EBPb and C/EBPd ChIP. EBPd À/À cells grown on a flat substrate were more rounded, with a poorly developed actin cytoskeleton and reduced focal adhesions, as demonstrated by a reduction in vinculin staining (Fig. 1b) . MEF C/ EBPd À/À cells also appeared more stellate with extensive arborisation and, although they underwent contact guidance on nanometric grooves, became much more elongated and were much less spread than MEF WT cells, particularly on 540 nm grooves. These results demonstrate that the transcription factor C/EBPd plays an essential role in efficient adhesion and spreading to both planar and nanometric grooved surfaces. These results are consistent with a recent report demonstrating that MEF C/EBPd À/À cells display increased migration when compared with MEF WT cells in wound healing assays [22] and suggests that C/EBPd may play a role in regulating the expression of genes involved in cell adhesion, movement and spreading.
Identification of C/EBPd consensus binding sites within the mouse genome
In order to test whether C/EBPd does in fact regulate gene expression associated with interactions with cell growth surfaces we carried out genomic analysis to identify the full range of genes and gene promoters regulated by C/EBPd in MEFs. We stimulated MEF WT and MEF C/EBPd À/À cells for 5 h with a combination of the pharmacological agents (F/R), forskolin, which promotes cyclic AMP synthesis, and rolipram, which inhibits cyclic AMP degradation, to increase the intracellular levels of C/EBPd protein through the activation of the C/EBPd gene [17] (Fig. 8) . As a comparison, and to ensure that we could identify genes specifically regulated by C/EBPd, C/EBPb WT and À/À cells were treated in a similar fashion. This was done because many of the cellular actions of C/EBPd are shared by C/ EBPb [17] . Following stimulation MEF WT cells were fixed, lysed and cellular chromatin isolated, fragmented and immunoprecipitated (ChIP) with anti-C/EBPd or anti-C/EBPb antibodies. The genomic DNA associated with ChIP'd samples was then sequenced using a genome analyser (ChIP-SEQ) to identify the C/EBPd are C/EBPb binding sites throughout the genome. The sequence reads were aligned to the mouse genome using the Bowtie aligner (version 0.12.7), which was set up to report only uniquely aligning reads, and duplicate reads were removed using Samtools (version 0.1.18). The Homer (version 3.9) suite of tools was used to verify that the majority of reads contained bone fide C/EBP-binding sites (Fig. 2a) .
To complement the ChIP-SEQ analysis, mRNA was also extracted from F/R-treated MEF C/EBPd WT, MEF C/EBPd À/À, MEF C/EBPb WT and MEF C/EBPb À/À cells. The extracted mRNA was then converted by reverse transcription to cDNA probes, which were then hybridised to mouse whole genome microarrays (Affymetrix). This approach was used so as to determine whether the genes that contain C/EBP-binding sites, identified by ChIP-SEQ, are also regulated at the level of transcription in a C/EBP-dependent manner. Genes identified as being regulated by F/R, or by deletion of either C/EBPd or C/EBPb, are listed in Supplementary Data Set 2. Custom scripts were then created to compare the list of known genes closest to ChIP peaks with gene lists generated from RNA microarray experiments (Supplementary Data Set 1). These corroborated gene lists were visualised on chromosomes using Circos plots (circos.ca; Supplementary Fig. 2 ) and a Venn diagram (Fig. 2b) . From these analyses we identified over 1100 genes that interact with C/EBPb alone and a similar number that interact with C/EBPd alone ( Fig. 2b; Supplementary Data Set 1) . Over 650 genes contain binding sites for both C/EBPb and C/EBPd ( Fig. 2b;  Supplementary Data Set 1) . Generally, C/EBPb and C/EBPd binding sites were distributed evenly throughout the cellular chromosomes ( Supplementary Fig. 2 ). Of the approximate 7800 genes identified by cDNA microarray as being regulated by the F/R treatment regime (Supplementary Data Set 2) , over 500 were identified as containing C/EBPb binding sites, over 500 contained C/EBPd binding sites and over 170 contained binding sites for both C/EBPb and C/EBPd ( Fig. 2b ; Supplementary Data Set 1). These figures far exceed the approximate 100 C/EBPd target genes previously identified through ChIPechip assays in a previous study [8] and demonstrates the sensitivity of our combined ChIP-SEQ and cDNA microarray approach. Taken together our data demonstrates that C/EBPb and C/EBPd isoforms interact promiscuously with the mouse genome through direct interaction multiple C/EBP-binding sites. Moreover, the fact that C/EBPd specifically interacts with over 1000 genes, independently of C/EBPb, suggests that C/EBPd may play a unique and specific role in the control of cell behaviour through the independent regulation of multiple gene regulatory networks.
Identification of genes whose expression is specifically regulated by C/EBPd
Results this far indicate that there are many regulatory C/EBPd binding sites distributed throughout the mouse genome. Accordingly, the identities of genes that contain C/EBPd binding sites are diverse and don't immediately describe shared functions (Supplementary  Data Set 1) . The same can be said for C/EBPb-interacting genes (Supplementary Data Set 1). Therefore, in order to further delineate the function of C/EBPd in MEFs we carried out CLUSTER analysis [18] on the F/R-induced gene expression changes that were identified by both cDNA microarray and SEQ analysis (Supplementary Data Set 2). CLUSTERs were generated for gene expression changes associated with C/EBPb (Fig. 3) , C/EBPd (Fig. 4) and shared (C/EBPb plus C/EBPd; which genes might be directly responsible for the effects of C/EBPd on cell adhesion, migration and spreading that we observed on planar and nanometric growth surfaces (Fig. 1) . We did note, however, that the RHO guanine nucleotide exchange factor 33 (ARHGEF33) appeared to be up-regulated in F/R-stimulated C/EBPd À/À cells (Fig. 4) , indicating a possible link between C/EBPd and the regulation of the tubulin cytoskeleton. Surprisingly we could not find any other C/EBPd-regulated, cytoskeleton linked gene identity in either of the C/EBPb or d ChIP-SEQ lists, apart from RHO-family GTPase 3 (RND3), which was associated with C/EBPb ChIP, and hence is likely to be trans-, rather than cis-, activated by C/EBPd. Consistent with a trans-activation role for C/EBPd, we did find a number of genes encoding cytoskeleton components in Fig. 6 (tubulin b2 (TUBB2), Keratin 16 (KRT16) and Keratin 20 (KRT20)), which details a CLUSTER of gene expression changes that do not match with ChIP-SEQ and therefore represent genes that are possibly trans-regulated by C/EBPs b and/or d. Transregulation by C/EBPd could occur through either the induction of expression of additional, "tertiary", transcription factor(s) or through the activation of autocrine/paracrine signalling mechanisms. Interestingly, in this respect, F/R treatment was found to up-regulate the expression of the gene encoding the autocrine/paracrine cytokine interleukin 6 (IL6), which is a C/EBPd-interacting gene whose expression was further enhanced in MEF C/EBPd À/À cells (Fig. 4) . We confirmed this observation by RT-PCR analysis of IL6 mRNA levels in C/EBP WT and C/EBP À/À cells ( Fig. 7b ) and contrasted these effects with the expression levels of the transcription factor nuclear receptor (NR) 4a3 and the signal transduction intermediate, insulin receptor substrate (IRS) 1, whose mRNA levels were either induced or repressed, respectively, following F/R treatment, but were unaffected by knockout of the C/EBPd gene (Fig. 7b) . Moreover, RT-PCR analysis confirmed that the genes encoding TUBB2, RND3, KRT16 and KRT20 were also induced by F/R treatment, consistent with a potential intermediary role for IL6, however only Krt20 was the only cytoskeletal component to be further induced following C/EBPd deletion, whereas TUBB2 and KRT16 expression was suppressed (Fig. 7a) . Basal levels of RND3 levels were enhanced in MEF C/EBP À/À cells, whereas actin levels were unchanged, demonstrating that C/EBPd is a general repressor of RND3 gene activity (Fig. 7a) . Together these results demonstrate that C/EBPd plays a central role in the regulated expression of cytoskeleton components (TUBB2, KRT16 and KRT20) and cytoskeleton regulators (ARHGEF33 and RND3) in MEFs. Since no direct interaction was detected between C/EBPd and the genes encoding these cytoskeletal components, it is likely that an intermediary, trans-activating element, such as C/EBPd-regulated IL-6 (Fig. 7b) , may be required for their regulation. These observations may go some way to explain the requirement for C/EBPd for proper adhesion and spreading on planar and nanometric growth surfaces described in Fig. 1. 
The role of SOCS3 in spreading and contact guidance on nanometric grooves
Another potential target for IL6-mediated, C/EBPd-dependent trans-activation is the suppressor of cytokine signalling 3 (SOCS3) gene. SOCS3 is known to be a direct target of IL6-receptor activation, mediated by tyrosine phosphorylated STAT3 transcription factors [23] . Moreover, we have shown that SOCS3 gene induction is absolutely required for efficient SOCS3 induction by F/R in vascular endothelial cells [17] . In the present study, we identified SOCS3 as being induced by C/EBPd-dependent F/R treatment of MEFs in microarray experiments (Fig. 6 ), Western blotting (Fig. 8a) and RT-PCR (Fig. 8b) , but not in ChIP-SEQ analysis. The SOCS3 gene encodes an E3 ubiquitin ligase which targets focal adhesionassociated FAK tyrosine kinase for proteolytic degradation [24, 25] compared the abilities of MEF WT and MEF SOCS3 À/À cell to attach and contact align to flat, 240 nm and 540 nm grooved growth surfaces (Fig. 9) . We found that, as with previous experiments, MEF WT cells attached and aligned to nanometric grooves effectively (Fig. 9a) . In contrast, MEF SOCS3 cells had an altered morphology, characterised by enhanced vinculin expression, and failed to contact align to either 240 nm or 540 nm grooves ( Fig. 9a  and b) . Consistent with a role for SOCS3 in controlling contact guidance, SOCS3 protein levels were found to be significantly reduced in MEF WT cells (Fig. 9c) . In contrast to MEF SOCS3 À/À cells, MEF FAK À/À cells did not show any appreciable difference in their ability to adhere and contact align to nanometric grooves ( Supplementary Fig. 3a and b) . This indicates that the requirement of SOCS3 for efficient alignment to nanometric grooves is independent of it ability to regulate FAK protein levels in cells.
Conclusions
In summary, we have used genomic analysis to demonstrate that C/EBPd is a transcription factor that is required for efficient attachment, spreading and alignment to nanometric grooves. This appears to occur through the trans-activation of genes encoding inducible cell signalling elements, such as SOCS3, cytoskeletal components, such as TUBB2, KRT16 and KRT20, and cytoskeletal regulators, such as ARHGEF33 and RND3. A possible mechanism for this trans-activation is through the cis-regulated induction of autocrine/paracrine mediators, such as IL6. Of these newly identified, C/EBPd-regulated genes, SOCS3 was found to be absolutely required for cells to be able to attach, align and spread on nanometric grooves. The fact that the effects of C/EBPd knockout on the interaction with nanometric grooves are much more subtle than those observed with SOCS3 knockout, suggests that the effects brought about by the loss of cellular C/EBPd can, to some extent, be compensated for by cellular C/EBPb, which we find to interact and regulate many of the same genes as C/EBPd (Fig. 2b) . Overall this study demonstrates the complexity of C/EBPd-controlled gene regulation and its importance for determining the nature of cell interactions with extracellular, nanometric cues.
